LF:VLFA07212p Farmakologie I - přednáška - Course Information
VLFA07212p Farmakologie I - přednáška
Faculty of Medicineautumn 2019
- Extent and Intensity
- 2/0/0. 1 credit(s). Type of Completion: k (colloquium).
- Teacher(s)
- doc. MUDr. Regina Demlová, Ph.D. (lecturer)
doc. PharmDr. Jan Juřica, Ph.D. (lecturer)
Mgr. Petra Amchová, Ph.D. (lecturer)
doc. RNDr. Ladislava Bartošová, Ph.D. (lecturer)
MUDr. Lea Janáková, Ph.D. (lecturer)
Mgr. Jana Kubátová, Ph.D. (lecturer)
doc. Mgr. MVDr. Leoš Landa, Ph.D. (lecturer)
MUDr. Jana Nováková, Ph.D. (lecturer)
MUDr. Jana Pistovčáková, Ph.D. (lecturer)
doc. PharmDr. Jana Rudá, Ph.D. (lecturer)
PharmDr. Jitka Rychlíčková, Ph.D. (lecturer)
Mgr. Barbora Říhová, Ph.D. (lecturer)
prof. MUDr. Dalibor Valík, Ph.D., DABCC (lecturer)
prof. RNDr. Lenka Zdražilová Dubská, Ph.D. (lecturer)
doc. PharmDr. Ondřej Zendulka, Ph.D. (lecturer)
Renata Bláblová (assistant)
MUDr. Filip Šiška (assistant)
Mgr. Martin Brož (alternate examiner)
Ing. Lenka Hořavová, Ph.D. (alternate examiner)
Mgr. Kateřina Nebeská (alternate examiner)
Mgr. Kristýna Nosková, Ph.D. (alternate examiner)
Květoslava Sedlářová (alternate examiner) - Guaranteed by
- doc. MUDr. Regina Demlová, Ph.D.
Department of Pharmacology – Theoretical Departments – Faculty of Medicine
Contact Person: doc. PharmDr. Ondřej Zendulka, Ph.D.
Supplier department: Department of Pharmacology – Theoretical Departments – Faculty of Medicine - Timetable
- Mon 16. 9. 14:00–15:40 B11/114, Mon 23. 9. 14:00–15:40 B11/114, Mon 30. 9. 14:00–15:40 B11/114, Mon 7. 10. 14:00–15:40 B11/114, Mon 14. 10. 14:00–15:40 B11/114, Mon 21. 10. 13:00–16:00 B11/114, Mon 4. 11. 14:00–15:40 B11/114, Mon 11. 11. 14:00–15:40 B11/114, Mon 18. 11. 14:00–15:40 B11/114, Mon 25. 11. 14:00–15:40 B11/114, Mon 2. 12. 14:00–15:40 B11/114, Mon 9. 12. 14:00–15:40 B11/114, Mon 16. 12. 14:00–15:40 B11/114, Mon 6. 1. 14:00–15:40 B11/114
- Prerequisites (in Czech)
- VLPF0622p Pathophysiol. II - lect. && VLPA0622c Pathology - practice
- Course Enrolment Limitations
- The course is also offered to the students of the fields other than those the course is directly associated with.
- fields of study / plans the course is directly associated with
- General Medicine (programme LF, M-VL)
- Course objectives
- The aims of the course are:
to explain the basic pharmacodynamic and pharmacokinetic processes and principles
to explain the basic principles of therapy of intoxications
to describe the factors that influence the drug effect - Learning outcomes
- Student after the course:
knows basic pharmacodynamic principles
knowns basic pharmacokinetic principles
knows basic factors that influence the effect of drugs
is able to suggest therapeutic measures in case of drug intoxication - Syllabus
VLFA07212p - Pharmacology I - Lectures
General medicine
Autumn semester 2019
- 17. 9. 2019 18:00-19:40, UKB A11/114
- PHARMACOLOGY AND ITS SUB-BRANCHES
- Course content: Definition of pharmacology and its sub-branches of pharmacology. Drug, medical product – basic pharmacological terminology. Sources of research and development of new drugs. Principles of correct drug use – types of pharmacotherapy and rational pharmacotherapy.
- 24. 9. 2019 18:00-19:40, UKB A11/114
- OVERVIEW OF DRUG DOSAGE FORMS
- Course content: Classification and overview of drug dosage forms for ready-made production and individual preparation, advantages and disadvantages of the particular types of drug dosage forms in clinical use, typical auxiliary substances (excipients). Drug dosage forms with controlled release.
- 1. 10. 2019 18:00-19:40, UKB A11/114
- ROUTES OF DRUG ADMINISTRATION
- Course content: Classification of routes of administration, description of the individual ways with examples of drugs. Overview of innovative administration routes.
- 8. 10. 2019 18:00-19:40, UKB A11/114
- PHARMACOKINETICS I
- Course content: General principles of drug's fate in the organism. Overview of the basic pharmacokinetic processes and parameters.
- 15. 10. 2019 18:00-19:40, UKB A11/114
- PHARMACOKINETICS II
- Course content: Single, continual and repeated drug administration. Principles of therapeutic drug monitoring. Compartment models. Fundamentals of population pharmacokinetics.
- 22. 10. 2019 18:00-19:40, UKB A11/114
- PHARMACODYNAMICS
- Course content: Mechanisms of drugs effects – classification, examples. Receptor theory – types of ligands and receptors. Change in drug effect after repeated administration.
- 29. 10. 2019 18:00-19:40, UKB A11/114
- PHARMACOVIGILANCE AND DRUG'S SAFETY
- Course content: Adverse effects of drugs - classification and characteristics. Pharmacovigilance in clinical research and practice. Therapeutic index, therapeutic range. Drug anamnesis, polypharmacy and introduction to drug interactions.
- 5. 11. 2019 18:00-19:40, UKB A11/114
- FACTORS AFFECTING DRUG'S EFFECTS
- Course content: Classification, overview and examples of factors affecting drug effects. Fundamentals of pharmacogenetics.
- 12. 11. 2019 18:00-19:40, UKB A11/114
- PHARMACOLOGY OF AUTONOMIC NERVOUS SYSTEM
- Course content: Overview of pharmacology of sympathetic and parasympathetic nervous system – neurotransmission, receptors. Basic indications of substances affecting ANS.
- 19. 11. 2019 18:00-19:40, UKB A11/114
- BASIC PRINCIPLES OF BIOLOGICAL THERAPY, BIOLOGICAL THERAPY OF RHEUMATOID AND GOUTY ARTHRITIS
- Course content: Definition of terms, advantages and disadvantages of biological treatment in comparison to conventional therapy. Fundamental principles of technologies used in production of biological medical products, their classification and examples of clinical use. Overview of biological drugs used in rheumatoid and gouty arthritis.
- 26. 11. 2019 18:00-19:40, UKB A11/114
- ANALGESIC DRUGS
- Course content: Classification of analgesic drugs. Basic pharmacological characteristics and examples of use of opioid analgesics, non-steroidal anti-inflammatory drugs and analgesic-antipyretic drugs.
- 3. 12. 2019 18:00-19:40, UKB A11/114
- GENERAL AND LOCAL ANAESTHETIC AGENTS
- Course content: Classification and pharmacological characteristics of general and local anaesthetic drugs.
- 10. 12. 2019 18:00-19:40, UKB A11/114
- PHARMACOTHERAPY OF DIABETES MELLITUS
- Course content: Insulins and anti-diabetic drugs – classification and basic pharmacological characteristics.
- 17. 12. 2019 18:00-19:40, UKB A11/114
- PHARMACOLOGY OF SEX HORMONES
- Course content: Analogues and antagonists FSH, LH. Oestrogens, antioestrogens, gestagens, antigestagens, androgens, antiandrogens basic pharmacological characteristics (classification, basic substances, therapeutic indications/contraindications, adverse effects).
- 7. 1. 2020 18:00-19:40, UKB A11/114
- IMMUNOPHARMACOLOGY - IMMUNOSUPPRESSANTS AND IMMUNOMODULATORS, BIOLOGICS
- Course content: Overview of drugs affecting immune system - classification, therapeutic use, basic pharmacological characteristics.
- Literature
- required literature
- RANG, H. P., James RITTER, R. J. FLOWER and Graeme HENDERSON. Rang & Dale's pharmacology. Eighth edition. [Edinburgh]: Churchill Livingstone, 2016, xv, 760. ISBN 9780702053627. info
- http://search.ebscohost.com/login.aspx?direct=true&db=nlebk&AN=1160493&lang=cs&site=ehost-live
- Životní cyklus léčiv, Demlová a kol., 2014, http://portal.med.muni.cz/clanek-621-zivotni-cyklus-leciv-klinicke-hodnoceni-a-registrace-lecivych-pripravku-farmakovigilance-a-stanovovani-cen-a-uhrad-leciv.html
- recommended literature
- https://portal.med.muni.cz/disciplina-13-farmakologie
- Landa Leoš, Jan Juřica, Kristýna Nosková, Ondřej Zendulka: Vybrané kapitoly z obecné farmakologie pro studenty všeobecného a zubního lékařství na LF MU. Multimediální podpora výuky klinických a zdravotnických oborů :: Portál Lékařské fakulty Masarykovy
- Základy farmakoekonomiky, Říhová a kol, 2016, http://portal.med.muni.cz/clanek-649-zaklady-farmakoekonomiky.html
- Soubor kazuistik z farmakologie, Zendulka a kol., 2016 http://elportal.cz/publikace/kazuistiky-farmakologie
- Základy speciální receptury léčivých přípravků, Juřica a kol., 2014, http://portal.med.muni.cz/clanek-611-zaklady-specialni-receptury-lecivych-pripravku.html
- Atlas léčivých rostlin, https://is.muni.cz/auth/do/med/el/lecive_rostliny/atlas.html
- Základy receptury léčivých přípravků. Nováková a kol., 2010, http://portal.med.muni.cz/clanek-553-zaklady-receptury-lecivych-pripravku.html
- ŠVIHOVEC, Jan a kol. Farmakologie, Praha: Grada, 2018. ISBN 978-80-247-5558-8. www.grada.cz/farmakologie-(1)-8687
- LINCOVÁ, Dagmar and Hassan FARGHALI. Základní a aplikovaná farmakologie. 2., dopl. a přeprac. vyd. Praha: Galén, 2007, xxiv, 672. ISBN 9788072623730. info
- not specified
- Farmakovigilance a propagace léčiv, Vršková a kol., 2007, http://portal.med.muni.cz/clanek-461-farmakovigilance-a-propagace-leciv.html
- Výzkum nových léčiv od zrodu k registraci, Starobová a kol., 2006, http://portal.med.muni.cz/clanek-367-vyzkum-novych-leciv-od-zrodu-k-registraci.html
- Farmakologie pro studenty bakalářských oborů na LF MU, Máchalová a kol., 2015, http://portal.med.muni.cz/clanek-644-farmakologie-pro-studenty-bakalarskych-oboru-na-lf-mu.html
- MARTÍNKOVÁ, Jiřina. Farmakologie pro studenty zdravotnických oborů. 2., zcela přeprac. a doplň. Praha: Grada, 2014. ISBN 9788024713564. info
- DOSTÁLEK, Miroslav, Jan JUŘICA, Eva JANOŠTÍKOVÁ and Lucia ZAHRADNÍKOVÁ. Farmakokinetika (Pharmacokinetics). ČR: Grada, 2006, 220 pp. Farmacie a farmakologie. ISBN 80-247-1464-7. info
- WHALEN, Karen. Pharmacology. Edited by Richard Finkel - Thomas A. Panavelil. 6th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins, 2015, xi, 664. ISBN 9781451191776. info
- Waller, Derek - Renwick, Andrew G. - Hillier, Keith. Medical pharmacology and therapeutics. 3rd ed. New York : Elsevier Saunders, 2009. ix, 744 p. ISBN 0-7020-2991-2.
- Ritter, James M. - Lewis, Lionel D. - Mant, Timothy G.K. - Ferro, Albert. A Textbook of Clinical Pharmacology and Therapeutics, 5th Ed., Hodder Arnold, 2008. 465 s. ISBN 978-0-340-90046-8
- Pharmaceutical practice. Edited by Judith A. Rees - Ian Smith - Jennie Watson. 5th ed. Edinburgh: Churchill Livingstone Elsevier, 2014, xvii, 552. ISBN 9780702051432. info
- Practicals in Pharmacology, 2009, Náhradní obsah: http://portal.med.muni.cz/article-491-practicals-in-pharmacology.html
- Teaching methods
- lectures, presentations by professionals in the sectors
- Assessment methods
- Colloquium - written ROPOT test: 40 multiple-choice questions with 3 to 5 options of asnwers. The number of correct answers is given.
Student gets 2 points for each completely correct answer, i.e. maximum 80 points for the whole multiple-choice test. Time limit: 60 min. The MCQ test can be repeated only twice.
To pass the colloquium successfully the student has to obtain at least 40 points. - Language of instruction
- Czech
- Further comments (probably available only in Czech)
- Study Materials
The course is taught annually.
Information on the extent and intensity of the course: 30. - Listed among pre-requisites of other courses
- VLFA08222c Pharmacology II - practice
VLFA07212p - VLFA08222p Pharmacology II - lecture
VLFA07212p - VLCH11Xpp Surgery - Pre-graduation Practice
VLSP03X && VLPD1033c && (VLPG9X1 || VLPG1022p) && VLAM9X1p && VLNE9X1p && (VLON9X1p || VLON091) && VLPY9X1p && VLCH9X33c && (VLIN9X22p || VLIN9X22) && VLVL101 && VLOZ1044 && VLAM9X1p && VLPX102t && VLAJ0222 && (VLLT0222 || VLLT0222s) && VLTZ0754 && vycet(3, VLADV071, VLAF091, VLAL081, VLIA081, VLKB091, VLKF091, VLNO071, VLPM071, VLPM081, VLRL081, VLTL081, VLAT081) && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c - VLCH11XX Surgery - State Exam
VLSP03X && VLPD1033c && (VLPG9X1 || VLPG1022p) && VLAM9X1p && VLNE9X1p && (VLON9X1p || VLON091) && VLPY9X1p && VLCH9X33c && (VLIN9X22p || VLIN9X22) && VLVL101 && VLOZ1044 && VLAM9X1p && VLPX102t && VLAJ0222 && (VLLT0222 || VLLT0222s) && VLTZ0754 && vycet(3, VLADV071, VLAF091, VLAL081, VLIA081, VLKB091, VLKF091, VLNO071, VLPM071, VLPM081, VLRL081, VLTL081, VLAT081) && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c - VLPD11Xpp Paediatrics - Pre-graduation Practice
VLSP03X && VLPD1033c && (VLPG9X1 || VLPG1022p) && VLAM9X1p && VLNE9X1p && (VLON9X1p || VLON091) && VLPY9X1p && VLCH9X33c && (VLIN9X22p || VLIN9X22) && VLVL101 && VLOZ1044 && VLAM9X1p && VLPX102t && VLAJ0222 && (VLLT0222 || VLLT0222s) && VLTZ0754 && vycet(3, VLADV071, VLAF091, VLAL081, VLIA081, VLKB091, VLKF091, VLNO071, VLPM071, VLPM081, VLRL081, VLTL081, VLAT081) && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c - VLPD11XX Paediatrics - State Exam
VLSP03X && VLPD1033c && (VLPG9X1 || VLPG1022p) && VLAM9X1p && VLNE9X1p && (VLON9X1p || VLON091) && VLPY9X1p && VLCH9X33c && (VLIN9X22p || VLIN9X22) && VLVL101 && VLOZ1044 && VLAM9X1p && VLPX102t && VLAJ0222 && (VLLT0222 || VLLT0222s) && VLTZ0754 && vycet(3, VLADV071, VLAF091, VLAL081, VLIA081, VLKB091, VLKF091, VLNO071, VLPM071, VLPM081, VLRL081, VLTL081, VLAT081) && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c - VLPG11XX Obstetric and Gynaecology - State Exam
VLSP03X && VLPD1033c && (VLPG9X1 || VLPG1022p) && VLAM9X1p && VLNE9X1p && (VLON9X1p || VLON091) && VLPY9X1p && VLCH9X33c && (VLIN9X22p || VLIN9X22) && VLVL101 && VLOZ1044 && VLAM9X1p && VLPX102t && VLAJ0222 && (VLLT0222 || VLLT0222s) && VLTZ0754 && vycet(3, VLADV071, VLAF091, VLAL081, VLIA081, VLKB091, VLKF091, VLNO071, VLPM071, VLPM081, VLRL081, VLTL081, VLAT081) && VLDD101I && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c - VLRL081 Medicinal plants
(VLFA07212p || VLFA07212p) - VLVL11Xpp Internal Medicine - Pre-graduation Practice
VLSP03X && VLPD1033c && (VLPG9X1 || VLPG1022p) && VLAM9X1p && VLNE9X1p && (VLON9X1p || VLON091) && VLPY9X1p && VLCH9X33c && (VLIN9X22p || VLIN9X22) && VLVL101 && VLOZ1044 && VLAM9X1p && VLPX102t && VLAJ0222 && (VLLT0222 || VLLT0222s) && VLTZ0754 && vycet(3, VLADV071, VLAF091, VLAL081, VLIA081, VLKB091, VLKF091, VLNO071, VLPM071, VLPM081, VLRL081, VLTL081, VLAT081) && VLCH0731p && VLDI7X1p && VLDV7X1p && VLFA07212p && VLKG7X1p && VLOR7X1c && VLPD7X31p && VLSD7X1p && VLCH0832p && VLFA08222p && VLOL7X1 && VLOT7X1p && VLPX084t && VLST7X1p && VLVL7X61 && VLAM9X1p && VLCH091 && VLDD91CH && VLIN9X22p && VLNE9X1p && VLON9X1p && VLOZ0943p && VLPD0932p && VLPG9X1 && VLPY9X1p && VLDD101I && VLOZ1044 && VLPD1033c && VLPX102t && VLSP03X && VLVL101 && VLVL9X62 && VLVL9X63c && VLVL9X64c && VLVL9X65c
- VLFA08222c Pharmacology II - practice
- Teacher's information
General pharmacology:
1. Pharmacology, sub-branches, origin of drugs, drug names.
2. Types of pharmacotherapy, rules of rational and safe phramacotherapy. The question of drug misuse.
3. Preclinical and clinical trials, stages.
4. Basic legislation related to drug use, Sources of information on drugs and medicinal products.
5. Solid and gaseous pharmaceutical drug dosage forms - overview and their influence on pharmacokinetics and pharmacodynamics.
6. Semi-solid and liquid pharmaceutical drug dosage forms - overview and their influence on pharmacokinetics and pharmacodynamics.
7. Routes of drug administration – overview, characteristics.
8. Drug absorption, presystemic elimination, drug bioavailability.
9. Drug distribution, volume of distribution, redistribution. General principles of drug movement through the body.
10. Drug elimination, processes of the first and zero order, drug accummulation.
11. Drug biotransformation – stages, examples.
12. Drug excretion (ways of excretion, possibilities of their influence).
13. Therapeutic monitoring of drugs (TDM).
14. Pharmacokinetics of single, repeated and continual drug administration.
15. Modes of drug action
16. Inhibition and induction of enzymes in pharmacokinetics and pharmacodynamics of drugs – examples.
17. Synergism and antagonism in drug effect (pharmacokinetics, pharmacodynamics).
18. Dose – response curves, types of doses, drug anamnesis, patient‘s adherence.
19. Adverse drug reactions (types, categories, examples).
20. Pharmacovigilance, drug safety.
21. Primary resistance of the patient to the treatment. Influence of repeated administration on drug efficacy - examples of tolerance and tachyphylaxis.
22. Factors influencing the drug effect – examples.
23. Pharmacotherapy in elderly, the influence of co-morbidities on drug effect, polypharmacy.
24. Pharmacotherapy in pediatric population, in breastfeeding women. Drugs influencing breast feeding.
25. Pharmacotherapy in pregnancy, drug teratogenicity.
26. Pharmacogenetics, influence of genetic polymorfisms on pharmacokinetics and pharmacodynamics of drugs.
27. Drug interactions - overview, examples.
28. Principles of biological treatment – classification, technology, examples of clinical use.
Special pharmacology:
1. Sympathomimetics - overview of single classes and their indications, examples of drugs
2. Sympatholytics - overview of single classes and their indications, examples of drugs
3. Cholinomimetics
4. Cholinolytics
5. Antispasmodics - GIT + UGT.
6. Glucocorticoids
7. Immunostimulants + immunosuppressants (except glucocorticoids)
8. Antidiabetics (except insulines)
9. Insulins
10. Sex hormones - contraception and HRT
11. Drugs targeting H-P axis and their indications (except contraception and HRT)
12. Uterotonics and tocolytics
13. Opioid analgesics
14. NSAIDs, non-opioid analgesics, antimigraine agents
15. Antiuratics, antirheumatics incl. DMARDs
16. General anesthetics
17. Local anesthetics
18. Muscle relaxants
19. Antipsychotics
20. Drugs of neurogenerative diseases (Parkinson’s disease; dementia)
21. Anticonvulsants
22. Nootropics, cognitives
23. Hypnosedatives, anxiolytics
24. Antidepressants - iMAO+SSRI+NDRI
25. Antidepressants - tricyclic, NASSA, MASSA, SARI, SNRI, NARI, SMS
26. Psychotomimetics, drugs used in ADHD
27. Antiasthmatics, drugs used in COPD
28. Antitussives, mucoactive drugs
29. H1 antihistamines
30. Hypolipidemics, anti-obesity drugs
31. Antihypertensives – drugs targeting RAAS
32. Antihypertensives – diuretics and aldosterone antagonists
33. Antihypertensives beta blockers + central antihypertensives
34. Antihypertensives - calcium channel blockers, α1 lytics
35. Antiangial agents
36. Antiarrhythmics
37. Drugs used in heart failure
38. Antiplatelet agents
39. Fibrinolytics, antifibrinolytics
40. Anticoagulants
41. Antianemics, hemostatics
42. Aminoglycosides
43. Principles of antibacterial therapy – overview, modes of action, resistance, MIC, MBC
44. Lincosamides, glycopeptides, polymyxins
45. Tetracyclines + related ATBs, amphenicoles
46. Cephalosporines, monobactams
47. Penicillins, carbapenems
48. Sulphonamides, nitrofurans and nitroimidazoles
49. Macrolides and related ATBs
50. Quinolones, antituberculotics
51. Antimycotics
52. Dermatologics – overview of classes, drugs and effects
53. Antivirotics
54. Antiemetic drugs, prokinetics, antivertigo drugs
55. Laxatives, antidiarrhoics, drugs of infectious diarrhoeas
56. Antiulcer agents, hepatoprotectives and drugs influencing the production and excretion of bile
57. Alkylating cytostatics and other drugs aiming on DNA in oncology
58. Biological treatment of autoimmune diseases
59. Targeted treatment in oncology
60. Antimetabolites + hormonal therapy in oncology
61. Drugs causing addiction
62. Drugs used in the treatment of addiction
63. General principles of drug poisoning, specific antidotes and their mechanisms of action
64. Drugs for inflammatory bowel disease
65. Drugs used in erectile dysfunction and BHP
66. Drugs used in osteoporosis, pharmacology of thyroid gland
67. Vitamins
68. Antiglaucomatics and cycloplegics
„Essential drugs“
1. adrenalin/noradrenalin
2. dobutamine
3. ephedrine/pseudoephedrine
4. phenylephrine
5. oxymetazoline
6. methyldopa
7. salbutamol
8. doxazosin
9. metoprolol
10. timolol
11. atropin
12. butylscopolamine
13. fenpiverine/pitofenon
14. pilocarpine
15. rivastigmine
16. physostigmine
17. solifenacin
18. dexametasone
19. prednisone
20. cyclosporine
21. interferons
22. methotrexate
23. metformin
24. glimepiride
25. sitagliptin
26. insulin lispro
27. insulin glargine
28. ethinylestradiol
29. cyproterone
30. tibolone
31. tamoxifen
32. hexoprenaline
33. oxytocin
34. levonorgestrel
35. paracetamol/ASA
36. ibuprofen/diclofenac
37. indometacin
38. nimesulide/meloxicam
39. buprenorphine
40. morphine/naloxone
41. sufentanil
42. tramadol
43. metamizole
44. allopurinol
45. sumatriptan
46. desflurane
47. propofol
48. ketamine
49. procaine/lidocaine
50. suxamethonium
51. prilocaine
52. haloperidol
53. olanzapine
54. aripiprazole
55. levodopa/carbidopa
56. diazepam
57. buspirone
58. piracetam/pyritinol
59. gabapentin/pregabalin
60. carbamazepine
61. valproic acid
62. zolpidem
63. midazolam
64. escitalopram
65. amitriptyline
66. mirtazapine
67. lithium
68. methylphenidate
69. acetylcysteine
70. codeine
71. butamirate
72. ipratropium-bromide
73. bisulepine/cetirizine
74. atorvastatine
75. fenofibrate
76. ezetimibe
77. isosorbid dinitrate/nitroglycerin
78. hydrochlorothiazide/indapamide
79. furosemid
80. spironolactone
81. amlodipin
82. perindopril
83. telmisartan
84. warfarin
85. enoxaparin
86. clopidogrel
87. dabigatran
88. rivaroxaban
89. alteplase
90. digoxin
91. amiodarone
92. verapamil
93. levosimendan
94. doxycycline
95. co-amoxicillin
96. phenoxymethylpenicillin
97. piperacillin
98. meropenem
99. cefuroxim
100. cotrimoxazol
101. clarithromycin
102. azithromycin
103. gentamicin
104. ciprofloxacin
105. vancomycin
106. rifampicin
107. terbinafine
108. caspofungin
109. amphotericin B
110. fluconazole
111. acyclovir
112. zidovudine
113. isotretinoin
114. salicylic acid
115. ondansetron
116. moxastine
117. pantoprazol
118. famotidin
119. lactulose
120. aprepitant
121. metoclopramid
122. loperamide
123. betahistine
124. cinnarizine
125. cyclophosphamide
126. methotrexate
127. 5-fluorouracil
128. paclitaxel
129. doxorubicin
130. cisplatin
131. trastuzumab
132. imatinib
133. interferon alfa
134. nivolumab
135. methadone
136. buprenorphine
137. nalmefene
138. naltrexone
139. finasteride
140. sildenafil
141. ibandronic acid
- Enrolment Statistics (autumn 2019, recent)
- Permalink: https://is.muni.cz/course/med/autumn2019/VLFA07212p